Report Detail
Global RNA Vaccines Market Growth 2019-2024
- RnM3161145 |
- 22 March, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
According to this study, over the next five years the RNA Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in RNA Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Vaccines market by product type, application, key manufacturers and key regions and countries.
This study considers the RNA Vaccines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Infectious Disease
Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global RNA Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of RNA Vaccines market by identifying its various subsegments.
Focuses on the key global RNA Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the RNA Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of RNA Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global RNA Vaccines Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global RNA Vaccines Consumption 2014-2024
- 2.1.2 RNA Vaccines Consumption CAGR by Region
- 2.2 RNA Vaccines Segment by Type
- 2.2.1 Individualized Cancer Treatment MRNA Vaccine
- 2.2.2 Infectious Disease Treatment MRNA Vaccine
- 2.2.3 Infection Prevention MRNA Vaccine
- 2.3 RNA Vaccines Consumption by Type
- 2.3.1 Global RNA Vaccines Consumption Market Share by Type (2014-2019)
- 2.3.2 Global RNA Vaccines Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global RNA Vaccines Sale Price by Type (2014-2019)
- 2.4 RNA Vaccines Segment by Application
- 2.4.1 Infectious Disease
- 2.4.2 Cancer
- 2.4.3 Other
- 2.5 RNA Vaccines Consumption by Application
- 2.5.1 Global RNA Vaccines Consumption Market Share by Application (2014-2019)
- 2.5.2 Global RNA Vaccines Value and Market Share by Application (2014-2019)
- 2.5.3 Global RNA Vaccines Sale Price by Application (2014-2019)
3 Global RNA Vaccines by Players
- 3.1 Global RNA Vaccines Sales Market Share by Players
- 3.1.1 Global RNA Vaccines Sales by Players (2017-2019)
- 3.1.2 Global RNA Vaccines Sales Market Share by Players (2017-2019)
- 3.2 Global RNA Vaccines Revenue Market Share by Players
- 3.2.1 Global RNA Vaccines Revenue by Players (2017-2019)
- 3.2.2 Global RNA Vaccines Revenue Market Share by Players (2017-2019)
- 3.3 Global RNA Vaccines Sale Price by Players
- 3.4 Global RNA Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global RNA Vaccines Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players RNA Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 RNA Vaccines by Regions
- 4.1 RNA Vaccines by Regions
- 4.1.1 Global RNA Vaccines Consumption by Regions
- 4.1.2 Global RNA Vaccines Value by Regions
- 4.2 Americas RNA Vaccines Consumption Growth
- 4.3 APAC RNA Vaccines Consumption Growth
- 4.4 Europe RNA Vaccines Consumption Growth
- 4.5 Middle East & Africa RNA Vaccines Consumption Growth
5 Americas
- 5.1 Americas RNA Vaccines Consumption by Countries
- 5.1.1 Americas RNA Vaccines Consumption by Countries (2014-2019)
- 5.1.2 Americas RNA Vaccines Value by Countries (2014-2019)
- 5.2 Americas RNA Vaccines Consumption by Type
- 5.3 Americas RNA Vaccines Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC RNA Vaccines Consumption by Countries
- 6.1.1 APAC RNA Vaccines Consumption by Countries (2014-2019)
- 6.1.2 APAC RNA Vaccines Value by Countries (2014-2019)
- 6.2 APAC RNA Vaccines Consumption by Type
- 6.3 APAC RNA Vaccines Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe RNA Vaccines by Countries
- 7.1.1 Europe RNA Vaccines Consumption by Countries (2014-2019)
- 7.1.2 Europe RNA Vaccines Value by Countries (2014-2019)
- 7.2 Europe RNA Vaccines Consumption by Type
- 7.3 Europe RNA Vaccines Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa RNA Vaccines by Countries
- 8.1.1 Middle East & Africa RNA Vaccines Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa RNA Vaccines Value by Countries (2014-2019)
- 8.2 Middle East & Africa RNA Vaccines Consumption by Type
- 8.3 Middle East & Africa RNA Vaccines Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 RNA Vaccines Distributors
- 10.3 RNA Vaccines Customer
11 Global RNA Vaccines Market Forecast
- 11.1 Global RNA Vaccines Consumption Forecast (2019-2024)
- 11.2 Global RNA Vaccines Forecast by Regions
- 11.2.1 Global RNA Vaccines Forecast by Regions (2019-2024)
- 11.2.2 Global RNA Vaccines Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global RNA Vaccines Forecast by Type
- 11.8 Global RNA Vaccines Forecast by Application
12 Key Players Analysis
- 12.1 Moderna Therapeutics
- 12.1.1 Company Details
- 12.1.2 RNA Vaccines Product Offered
- 12.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Moderna Therapeutics News
- 12.2 CureVac
- 12.2.1 Company Details
- 12.2.2 RNA Vaccines Product Offered
- 12.2.3 CureVac RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 CureVac News
- 12.3 Translate Bio
- 12.3.1 Company Details
- 12.3.2 RNA Vaccines Product Offered
- 12.3.3 Translate Bio RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Translate Bio News
- 12.4 BioNTech
- 12.4.1 Company Details
- 12.4.2 RNA Vaccines Product Offered
- 12.4.3 BioNTech RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 BioNTech News
- 12.5 Sangamo Therapeutics
- 12.5.1 Company Details
- 12.5.2 RNA Vaccines Product Offered
- 12.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Sangamo Therapeutics News
- 12.6 Argos Therapeutics
- 12.6.1 Company Details
- 12.6.2 RNA Vaccines Product Offered
- 12.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Argos Therapeutics News
- 12.7 In-Cell-Art
- 12.7.1 Company Details
- 12.7.2 RNA Vaccines Product Offered
- 12.7.3 In-Cell-Art RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 In-Cell-Art News
- 12.8 eTheRNA
- 12.8.1 Company Details
- 12.8.2 RNA Vaccines Product Offered
- 12.8.3 eTheRNA RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 eTheRNA News
- 12.9 Ethris
- 12.9.1 Company Details
- 12.9.2 RNA Vaccines Product Offered
- 12.9.3 Ethris RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Ethris News
- 12.10 Tiba Biotechnology
- 12.10.1 Company Details
- 12.10.2 RNA Vaccines Product Offered
- 12.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Tiba Biotechnology News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on RNA Vaccines . Industry analysis & Market Report on RNA Vaccines is a syndicated market report, published as Global RNA Vaccines Market Growth 2019-2024. It is complete Research Study and Industry Analysis of RNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
